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ABSTRACT                           In this paper we provide evidences that protein phosphatases could regulate 
the intracellular localization of caveolin isoforms in a hepatoma cell line (HepG2). Ocadaic acid 
(OA) - a serine/threonine phosphatase inhibitor – was used in various concentrations (4nM and 
100nM) to study the localization of caveolin-1 and caveolin-2 in HepG2 cells. Using fluorescent 
and confocal immunocytochemistry we have found that OA in both concentrations has signifi-
cantly altered the intracellular localization and distribution of the caveolin-1 and caveolin-2 as 
well. In control (-OA treatment) the caveolin-1 was present in discrete punctate structures in 
the cytoplasm and also on the cell membrane. Caveolin-2 has partly overlapped with caveolin-1, 
but a significant amount caveolin-2 was detected around the nucleus. After OA (4 and 100 nM) 
treatment caveolin-1 has disappeared from the cell membrane, it was present mainly in the 
cytoplasm in larger vesicle or vacuole-like structures that were arranged along the cables of the 
cytoskeleton. In many cases caveolin-2 was found to colocalize with caveolin-1, but there was 
always a significant amount of caveolin-2 present around the nucleus. Immunoprecipitation and 
Western blot analysis revealed that in OA-treated cells a ~24 kDa protein identified as caveolin-
2 was strongly phosphorylated on tyrosine residues. The effect of OA was not reversible, since 
the removal of OA has not resulted in the dephosphorylation of caveolin-2 and the perinuclear 
localization of caveolin-2 remained. Our data indicate that phophorylation of caveolin-2 can alter 
not only the intracellular localization of caveolin isoforms but also the distribution of caveolae. 
The cytoskeleton seems to play an important role in the normal and altered distribution of 
caveolae, and the tyrosine phosphorylation or the absence of dephosphorylation of caveolin-2 
isoform can inhibit the recycling of caveolae. 
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Caveolae have been morphologically characterized as ome-
ga- or flask-shaped plasma membrane invaginations and 
biochemically as caveolin- and cholesterol-rich membrane 
domains (Kurchalia and Parton 1999). Caveolins are es-
sential for caveolae formation, they constitute the structural 
framework of caveolae (Parton 1996). Three members of the 
caveolin gene family have been identified so far: caveolin-
1, caveolin-2 and caveolin-3. Caveolin-1 induces caveolae 
formation, binds cholesterol, and interacts with signaling 
molecules. Caveolin-3, expressed in limited kinds of cells 
(muscle cells, Tang et al. 1994; Song et al. 1996; Way and 
Parton 1999; glials cells, Nishiyama et al. 1999; neurons, 
unpublished data, etc.), is thought to play similar role to that 
of caveolin-1. The function of caveolin-2 has not yet been 
defined in details. Data indicate its accessory role in caveo-
lae formation, as well as its involvement in forming deep 
caveolae invaginations (Scheiffele et al. 1998; Fujimoto et 
al. 2000; Kiss et al. 2000). 
Caveolae seem to have multiple functions. Wide variety 
of signaling molecules (GPI-anchored proteins, intermediates 
of the MAP kinase phosphorylation cascade including h-Ras, 
Fyn, Src family tyrosine kinases, eNOS, heterotrimeric G 
proteins, G-protein-coupled receptors) have been found to be 
accumulated in caveolae (Anderson, 1998; Smart et al. 1999). 
These signaling molecules bind to caveolin itself (Couet et 
al. 1997). As a result of this binding the signaling molecules 
become inactive (Li et al. 1995), thus caveolae assumed to 
function as preassembled signaling complexes, message cen-
ters, signaling organelles (Smart et al. 1999). Caveolae also 
play an important role in the regulation of cellular cholesterol 
homeostasis (Fielding and Fielding 2000).
Caveolae take part in cellular transport as well. Increasing 
number of evidences confirm that caveolae are directly 
involved in the internalization of membrane components, 
extracellular ligands such as cholera toxin (Montesano et al. 
1982; Parton et al. 1994), folic acid (Rothberg et al. 1990; 
Anderson et al. 1992), serum albumin (Scnitzer et al. 1994), 
autocrine motility factor-AMF (Berliname et al. 1998), GPI-
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anchored proteins (Anderson 1992) green fluorescent protein 
(Nichols et al. 2001), urokinase receptors (Stahl amd Mueller 
1995). Certain filamentous adhesin (FimH)-expressing 
bacteria are also internalized in caveolae-dependent pathway 
in immune cells (reviewed by Harris et al. 2002). Several 
nonenveloped viruses (Simian virus 40, Polyoma virus) enter 
cells through caveolae (Pelkmans et al. 2001; Pelkmans and 
Helenius 2002).
It has been postulated that phosphatases and kinases can 
regulate the internalization, and probably, the recycling of 
caveolae. In our experiments ocadaic acid (OA) was used to 
study the internalization and possible recycling of caveolae 
in HepG2 cell line. When hepatoma cells were treated with 
OA (4 and 100 nM), the cytoplasmic and plasma membrane 
distributions of caveolin-1 and caveolin-2 have changed. 
Caveolin-1 has disappeared from the cell surface and it was 
detected in vesicles arranged in rows in the cytoplasm. Since 
caveolae can be characterized by the presence of caveolin-1 
and caveolin-2 (caveolin-2 seems to play an accessory role in 
caveolae-formation), the cytoplasmic route of caveolae can 
be followed by detection (localization) of these isoforms, so 
we think that caveolae have also disappeared from the cell 
surface. Although caveolin-2 was partly colocalized with 
caveolin-1, there was a significant amount of this isoform 
present in the perinuclear region. When OA was removed and 
the cells were incubated with an OA-free medium for 3 hours 
caveolin-1 was still arranged along cables, while caveolin-2 
was detected around the nucleus. This perinuclear caveolin-
2-containing ring was more prominent then in control cells. 
We were not able to detect caveolin-1 and –2 in punctate 
structures on the cell membrane. Our immunoprecipitation 
and Western blot analyses showed that OA treatment has 
resulted in tyrosine phosphorylation of a ~24 kDa caveolin-
2. When the cells were incubated with OA-free medium for 
3 hours, the tyrosine phosphorylation of caveolin-2 became 
stronger indicating that the effect of OA was not reversible. 
From these data we conclude that tyrosine phosphorylation of 
caveolin-2 plays an important role in the regulation of caveo-
lin and caveolae distribution/localization in the cyto-plasm. 
Cytoskeleton seems to be involved in this procedure. 
Materials and Methods
Materials
HepG2 hepatoma cell line was used for all experiments. The 
monoclonal antibodies (anti-caveolin-1 and anti-caveolin-2) 
were purchased from Transduction Laboratories, (Lexington, 
KI, USA). Anti-caveolin-1N, anti-caveolin-2 antibodies as 
well as anti-phosphotyrosine caveolin-1 have been purchased 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
Antibody against phosphotyrosine (4G40) was obtained 
from Upstate Biotechnology. The horseradish peroxidase-
conjug-ated (HRP) anti-mouse and anti-rabbit IgG and the 
pre-stained standard protein markers were Bio-Rad (Hercules, 
CA, USA) products. The ECL nitrocellulose filter and the 
ECL reagent were manufactured by Amersham Bioscience 
Trading GmbH (Vienna, Austria). Protein phos-phatase 2A1 
and protein tyrosine phosphatase (LAR) were purchased from 
Calbiochem (Lucerne, Switzerland).
Biotinylated anti-mouse IgG was obtained from Vector 
Laboratories (Burlingame, CA, USA), Alexa-conjugated 
anti-rabbit antibody (488 nm) and Alexa-conjugated avidin 
(594 nm) were purchased from Molecular Probes (Eugene, 
OR, USA). 
Western blot analysis
HepG2 cells were solubilized with 1% SDS in 20 mM TRIS-
HCL buffer, (pH 7.4) and boiled for 4-5 min. The protein 
contents of the lysates were measured with Lowry’s method. 
10-30 mg protein was separated on gradient (8-12% acry-
lamide) SDS-PAGE and transferred to nitrocellulose filters. 
The filters were blocked with 3% BSA (dissolved in 0.1% 
Tween-PBS). Incubation was carried out with anti-caveolin-
1 (VIP21) IgG (1:250), or anti-caveolin-2 (1:250) antibody. 
The second antibody (anti-rabbit IgG-HRP) was diluted to 
1:10,000 (for anti-caveolin-1) and 1:3,000 (for anti-caveo-
lin-2). The conditions of immunoblotting (incubation time, 
washing, ECL detection) were chosen as suggested by the 
manufacturer (Amersham Bioscience). After ECL detection 
the results were evaluated with an LKB Laser Densitometer 
using the GelScan program.
Immunoprecipitation
Cells (107) were lysed in 200 ml solubilization buffer (50 





, 1 mM NaF, 10% glycerol, 0.5% Nonidet P40, 0.1 
mM PMSF, 10 mg/ml aprotinin). The lysates were incubated 
with specific antibodies, anti-caveolin-1 and anti-caveolin-2, 
for 5 h at 4°C. Immune complexes were formed by addition 
of protein-A-Sepharose 4B and incubated for 1 h at 4°C. The 
immune complexes were then sedimented by centrifugation 
at 12,000 g, followed by 4-5 washes in lysis buffer. Bound 
proteins were solubilized and analyzed on SDS-PAGE, foll-
wed by immunoblotting. In some exper-imental groups the 
immunoprecipitates were treated with tyrosine phophatase 
(15 min at 25°C) dissolved in a buffer containing 20 mM 
Tris-HCL and 1 mM EDTA (pH 7.4).
Immunocytochemistry
HepG2 cells were fixed in methanol-aceton mixture at -20°C. 
After fixation endogenous biotin was blocked, then the cells 
were washed. To prevent aspecific binding the cells were 
treated with 1% BSA/PBS and incubated with anti-caveolin-1 
(1:200) and anti-caveolin-2 (1:100) antibodies for over-night. 
After washig (3 times in 0.1% Triton-X 100 containing PBS) 
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anti-caveolin-1 was detected with Alexa-conjugated anti-rab-
bit IgG (488 nm, 1:100) To detect caveolin-2 a second anti-
body (biotinylated anti-mouse IgG in 1:100 dilution) was used 
and it was visualized with Alexa-conjugated avidin (594 nm, 
1:100). Fluoromont was used to cover the cells. The samples 
were studied with Zeiss Axiophot microscope and with MRC 
1024 Bio-Rad confocal scanning microscope.
Results
The effect of ocadaic acid on the intracellular 
distribution of caveolin-1 and caveolin-2 
isoforms
When we used fluorescent and confocal immunocytochem-
istry we have found that OA in both 4 and 100nM concentra-
tions has significant effect on the intracellular distribution of 
the caveolin-1 and caveolin-2 as well. In control (-OA treat-
ment) the caveolin-1 was found in small punctate structures 
on the plasma membrane, but it was also detectable all over 
the cytoplasm. (Fig.1b) There was no preferential localization 
or cluster of these isoform. Caveolin-2 showed some colocal-
ization with caveolin-1, but a significant amount caveolin-2 
was detected around the nucleus (Fig 1c). After OA (4 and 
100 nM) treatment caveolin-1 has disappeared from the cell 
membrane, it was present mainly in the cyto-plasm in larger 
vesicles or vacuole-like structures (Fig. 2b and Fig. 3b). Most 
of these vesicles were arranged in rows, along cable-like 
structures suggesting that the cytoskeleton must be involved 
in remodelling of the caveolin distribution pattern. Although 
in many cases caveolin-2 was found to colocalize with ca-
veolin-1, there was always a significant amount of caveolin-2 
present around the nucleus (Fig. 2c and Fig 3c). When OA 
was removed and the cells were incubated for 3 hours in an 
OA-free culture medium the perinuclear localization of ca-
veolin-2 remained (Fig 4c and Fig 5c) while caveolin-1 was 
found to follow the arrangement of the cytoskeleton. (Fig 4b 
and Fig 5b).
The effect of ocadaic acid on the 
phosphorylation of caveolin isoforms
When we immunoprecipitate proteins from the lysate of 
HepG2 cells with anti-caveolin-2 antibody a 24 kDa protein 
was the only one immunoprecipited with this antibody. When 
we used anti-caveolin-2 antibody this 24 kDa band showed a 
strong labelling indicating that this protein is caveolin-2. Our 
Western blot analysis revealed that in OA-treated cells this 
24 kDa protein (caveolin-2) was strongly phosphorylated on 
tyrosine residues (Fig 6 H/4 and H/100), giving evidence that 
OA treatment induces a strong tyrosine phosphorylation of 
caveolin-2 in HepG2 cells. The effect of OA was not revers-
ible, since the removal of OA has not resulted in the dephos-
phorylation of caveolin-2 (Fog 6 RH/4 and RH/100). 
Discussion 
It has been generally accepted that besides clathrin-coated 
uptake mechanism alternative endocytotic pathways also 
exist. There are several candidates by which this alternative 
uptake can occur, one of them is the endocytosis via caveolae. 
Although it has been debated for a long time that caveolae can 
pinch off from the plasma membrane to form primary endo-
cytotic vesicles (Anderson 1993; Van Deurs et al. 1993), there 
is an increasing body of evidence confirming that caveolae do 
pinch off from the plasma membrane and are directly involved 
Figure1. The intracellular localization of caveolin-1 (B) and caveolin-2 
(C) in control (no OA treatment cells. (A) phase contrast micrograph 
of a HepG2 cell. Caveolin-1 was found on discrete punctate structures 
on the cell surface and also in the cytoplasm (B). Caveolin-2 has partly 
overlapped with caveolin-1, but there is a preferential localization 






in the internalization of membrane com-ponent, extracellular 
ligands (Parton et al. 1994; Schnitzer et al. 1994; Berliname 
et al. 1998; Monteasno et al. 1998; Nichols et al. 2001; Stahl 
and Mueller 1995). 
The caveolae-mediated endocytosis differs from clathrin-
mediated pathway in many respects. In contrast to clathrin-
coated endocytosis, the internalization of caveolae seems 
to be regulated by kinases and phosphatases. The increased 
phosphorylation of proteins associated with caveolae (Parton, 
1994; Smart et al. 1995) or caveolin isoforms themselves 
(Aoki et al. 1999) stimulate caveolae to pinch off, and 
dephosphorylation of these protein might be required for 
recycling of these vesicles to the cell surface (Smart et 
al. 1995). The precise mechanism, substrates as well as 
kinases and phophatases taking part in this dephosphorylation 
procedure are not known. In order to study the effect of 
phosphorylation/dephosphorylation on the surface distri-
bution and cytoplasmic localization of caveolin isoforms we 
have used ocadaic acid (OA). OA is a well-known serine/
threonine (PP1 and PP2) protein phosphatase inhibitor (Wera 
and Hemmings 1995).
Our immunocytochemical studies showed that as a result 
of OA treatment in HepG2 cells the cytoplasmic and plasma 
membrane distributions of caveolin-1 and caveolin-2 have 
changed. Caveolin-1 has disappeared from the cell surface 
and was detected in vesicles arranged in rows in the cyto-
Figure 2. The effect of 4 nM OA treatment on the cellular distribution 
of caveolin-1 and caveolin-2. (A) phase contrast micrograph of HepG2 
cells. After 30min OA treatment caveolin-1 has disappeared from the 
plasma membrane and was present in rows (B). Caveolin-2 was found 
in similar localization, but caveolin-2 containing perinuclear ring was 
still present (C). Magnification: 1000x
Figure 3. The effect of 100 nM OA on the cellular distribution of 
caveolin-1 and caveolin-2. (A) phase contrast micrograph of HepG2. 
Caveolin-1 was present in the periphery of the cytoplasm and it was 
arranged in rows (B). The caveolin-2 localization was similar to the 4 
nM OA-treated cells (C). Magnification: 1000x
 A
 A
 B  B
 C  C
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plasm. Since caveolae can be characterized by the presence 
of caveolin-1 and caveolin-2 (caveolin-2 seems to play an 
accessory role in caveolae-formation), the cytoplasmic route 
of caveolae can be followed by detection (localization) of 
these isoforms. From these data we think that caveolae have 
also disappeared from the cell surface. Although caveolin-2 
was partly colocalized with caveolin-1, there was a signifi-
cant amount of this isoform present in the perinuclear region. 
When OA was removed and the cells were incubated with 
an OA-free medium for 3 hours the localization pattern of 
the caveolin isoforms has changed again. Caveolin-1 was 
still arranged along cables, while caveolin-2 was detected 
around the nucleus. This perinuclear caveolin-2-containing 
ring was more prominent then in control cells. We were not 
able to detect caveolin-1 and –2 in punctate structures on the 
cell membrane. Our immunoprecipitation and Western blot 
analysis showed that OA treatment has resulted in tyrosine 
phosphorylation of a ~24 kDa protein which was identified 
as caveolin-2. When the cells were incubated with OA-free 
medium for 3 hours the tyrosine phosphorylation of the ca-
Figure 4. When 4 nM OA was removed and the cells were incubated 
in OA-free medium for 3 hours caveolin-1 was still present in the cy-
toplasm (in rows) and not on the cell membrane (B). The distribution 
of caveolin-2 has not changed (C) Magnification: 1000x
Figure 5. After 3 hours incubation in OA-free medium the effect of 
100 nM OA was not found to be reversible. There was no caveolin-1 
containing vesicles present on the plasma membrane (B), and caveolin-
2 was found around the nucleus (C). Magnification: 1000x
 A
   A
 B
   B
 C    C
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veolin-2 became stronger indicating that the effect of OA was 
not reversible. Although OA is a serine/threonine phophatase 
inhibitor, we propose that OA treatment causes tyrosine phos-
phorylation of caveolin-2 indirectly, through phosphorylation 
of other members of a phosphorylation cascade. It is known 
that the Src family tyrosine kinases can be efficiently blocked 
by PP1 and PP2 phosphatases (Marinissen and Gutkind 
2001). Since caveolin was first identified as a substrate for 
phosphorylation by v-src (Glenney and Zokas 1989), and 
Src kinases were also found to be associated with caveolae 
(reviewed by Anderson 1998), we suggest that OA causes 
tyrosine phos-phorylation of caveolin isoforms through this 
phosphorylation cascade.
From these results we conclude that the tyrosine phos-
phorylation of caveolin-2 can be responsible for removal 
of caveolae from the cell surface. Since there are data sug-
gesting that dephosphorylation of proteins associated with 
caveolae would be necessary for caveolae recycling (Smart 
et al. 1995), we think that in OA treated cells caveolae can 
not recycle back to the cell surface. Our data strongly sug-
gest that tyrosine phosphorylation of caveolin-2 plays an 
im-portant role in the regulation of caveolin and caveolae 
distribution/localization in the cytoplasm. Cytoskeleton seems 
to be involved in this procedure. 
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